Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq
Saunder-led Allergan is buying body-sculptor Zeltiq. Saunder deems it to be the Botox of 10 years ago; expects the deal to be immediately accretive.
from Biotech News
Saunder-led Allergan is buying body-sculptor Zeltiq. Saunder deems it to be the Botox of 10 years ago; expects the deal to be immediately accretive.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments